Preventive Care Plans and Guidelines
Guidelines for Female, Age 35 to 49
The following recommendations are categorized for “men” and “women,” and are driven by biological sex (male and female) rather than gender identity. Meet with your doctor to determine which recommendations best apply to you based on individual factors, such as your sex assigned at birth and current anatomy.1
Screenings
Annually
- Body Mass Index (BMI)
- Blood pressure
- Height and weight
- Skin
- Teeth cleaning (every 6 months)
- Well-doctor exam
- Depression and suicide risk
- Anxiety
Every 1-3 years
- Breast cancer mammogram
Every 3 years
- Pelvic & pap for cervical cancer (talk to your doctor about frequency, especially at age 30)
Every 5 years
- Cholesterol (starting at age 40 or more frequently if you’re at high risk for coronary disease)
- Eyes (May need screenings every 1-2 years beginning at age 40)
As needed
- Colorectal cancer (starting at age 45, your doctor may suggest any one of these tests based on screening type and risk):
- Direct visualization tests: colonoscopy, CT colonography, flexible sigmoidoscopy
- Stool-based tests: fecal immunochemical test (FIT), guaiac-based fecal occult blood test (gFOBT), multi-targeted stool DNA test (FIT-DNA)
- Cardiovascular (CVD) Risk Assessment (screen as your doctor suggests between 40 and 75)
- Hearing
- Hepatitis C (screen once between ages 18 and 79)
- Hepatitis B
- Tobacco, alcohol, and substance abuse counseling
- Type 2 diabetes
- Sexually Transmitted Infections (STI’s)
- HIV
Vaccines
For more information about vaccines and the current recommendations on COVID-19 vaccinations, visit cdc.gov/vaccines.
Annually
- Influenza (flu)
Every 10 years
- Tetanus/Diphtheria/ Pertussis (Tdap)
As needed
- Pneumonia (certain adults ages 18 to 65 who are at risk should receive both a PCV13 and PPSV23; your doctor should suggest dosage)
- Pneumococcal 13-valent conjugate (PCV13)
- Pneumococcal polysaccharide (PPSV23)
- Varicella (Chickenpox)
- COVID-19
1 Caughey AB, Krist AH, Wolff TA, et al: USPSTF Approach to Addressing Sex and Gender When Making Recommendations for Clinical Preventive Services. JAMA. (November 16, 2021): pubmed.ncbi.nlm.nih.gov/34694343.